Amyloid Responsive Microglia is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Amyloid-Responsive Microglia (ARM) are microglia that specifically respond to amyloid-beta deposition in Alzheimer's disease, adopting a unique activation state distinct from both homeostatic microglia and disease-associated microglia (DAM).
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
Upon detection of amyloid-beta aggregates, microglia undergo dramatic transcriptional and functional changes, transitioning through distinct activation states.
ARM upregulate:
These microglia show:
ARM demonstrate:
Homeostatic microglia:
Upon Aβ detection:
Overactivated microglia:
Microglia recognize Aβ through:
Aβ internalization occurs via:
The study of Amyloid Responsive Microglia has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.